Tolerogenixx raises €25K Pre-Seed round
14 July 2015· Heidelberg, Germany· health, immunotherapy, biotech, b2b, deep_hardware
Public grant and pre-seed support (including EXIST-Forschungstransfer) to support the spin-off from Heidelberg University Hospital and early pre-clinical development of its cell therapy technique.
Investors
LeadGerman Federal Ministry for Economic Affairs and Climate Action
About Tolerogenixx
Stage
Series A
Headquarters
Heidelberg, Germany
Founded
2016
Team Size
6–20
Sectors
healthimmunotherapybiotechb2bdeep_hardware